Thomas Orsak, PhD, focuses his practice on intellectual property matters that include domestic and foreign patent prosecution, enforcement and strategic development of patent portfolios. Thomas's experience emphasizes biotechnology and chemical processing and formulation matters, including genetic engineering, gene therapy, molecular biotechnology assays, drug screening and targeting, enzymology, medical technology, plants, organic chemistry, pharmaceutical development, medical devices, polymers, chemical refining and chemical production.
Thomas counsels clients regarding the development, management, and commercialization of commercially valuable intellectual property portfolios on a global scale. In 2019, Thomas participated in a part-time secondment of more than four months with a global wound care company. Through this secondment, he received the unique and invaluable opportunity to work closely with the company's in-house lawyers and gained in-depth exposure to many aspects of the company's business.
Thomas's patent prosecution practice includes all aspects of drafting and prosecuting patent applications before the United States Patent and Trademark Office (USPTO), including appeals before the Patent Trial and Appeal Board (PTAB). He also supervises the prosecution of patent applications before many foreign patent offices. Thomas has extensive experience preparing patentability, freedom to operate (FTO), non-infringement and infringement analyses and opinions.
Thomas has also provided pro bono patent prosecution services to individual inventors.
Representative experience
- Preparing patent applications, responses to office actions, appeal briefs, examiner interviews and a variety of related prosecution matters
- Formulating strategies for prosecuting patent applications in foreign jurisdictions and supervising execution of those strategies
- Strategic portfolio development for small, medium and large companies and universities
- Development and management of strategies, opinions and process of IP review and clearance during and after product development
- Monitoring and maintenance of companies' patent portfolios
- Strategic commercialization and licensing of intellectual property
- Applications for Plant Variety Protection
- Working closely with in-house lawyers at a global wound care company during a secondment at the company's headquarters
Awards and recognitions
- Best Lawyers: Ones to Watch in America, Patent Law, Best Lawyers, 2025 – 2026
Education
- JD, Georgetown Law, 2014
- PhD, Biochemistry, University of Utah, 2011
- BS, Biochemistry, Brigham Young University, 2004
Admissions
- Texas State Bar
- US Patent and Trademark Attorney
Speaking engagements
- "Intellectual Property Practice," 5th Annual San Antonio Conference on Stem Cell Research & Regenerative Medicine
- "Intellectual Property Practice," 6th Annual San Antonio Conference on Stem Cell Research & Regenerative Medicine
Publications
- Co-author, "Obviousness-type double patenting, terminal disclaimers and best IP practices," Insights, Norton Rose Fulbright, September 14, 2023
- Co-author, "Intellectual property in consumer brands and company valuations: Implications for mergers," Insights (Republished in The Fashion Law), Norton Rose Fulbright, May 11, 2023
- Co-author, "Consumer products and IP (Part 6): deriving a copyright for consumer products," Consumer Products Law Blog, Norton Rose Fulbright, September 13, 2021
- Co-author, "Consumer products and IP (Part 5): the download on trademarks for consumer products," Consumer Products Law Blog, Norton Rose Fulbright, August 11, 2021
- Co-author, "Consumer products and IP (Part 4): demystifying the impact of trade secret misappropriation for consumer products," Consumer Products Law Blog, Norton Rose Fulbright, June 30, 2021
- Co-author, "Consumer products and IP (Part 3): the intersection between consumer products and design patents," Consumer Products Law Blog, Norton Rose Fulbright, May 25, 2021
- Co-author, "Consumer products and IP (Part 2): what's a patent got to do with it?" Consumer Products Law Blog, Norton Rose Fulbright, May 20, 2021
- Co-author, "Consumer products and IP (Part 1): why it matters," Consumer Products Law Blog, Norton Rose Fulbright, May 17, 2021
- Co-author, "Stream-of-commerce considerations for consumer product patent infringement claims," Consumer Products Law Blog, Norton Rose Fulbright, December 15, 2020
- Co-author, "Healthcare and Technology," Texas Bar Annual Meeting, June 17, 2016
- Co-author, "US Supreme Court Rules Isolated DNA is Not Patent-Eligible," Norton Rose Fulbright Legal Update, June 18, 2014
- Co-first author, "A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans," Science, Vol. 337 no. 6090, pp. 96-100, July 6, 2012
- First author, "Revealing the Allosterome: Systematic Identification of Metabolite-Protein Interactions," Biochemistry, Vol. 51 no. 1, pp. 225-232, January 10, 2012
Membership and activities
- Texas Austin Chapter Chair, J. Reuben Clark Law Society
- Austin Intellectual Property Law Association (AIPLA)
- State Bar of Texas
- US Patent and Trademark Office